Vermeer M H, Geelen F A, van Haselen C W, van Voorst Vader P C, Geerts M L, van Vloten W A, Willemze R
Department of Dermatology, Free University Hospital, Amsterdam, The Netherlands.
Arch Dermatol. 1996 Nov;132(11):1304-8.
Primary cutaneous follicular center cell lymphomas represent a distinct type of cutaneous B-cell lymphoma, clinically characterized by localized skin lesions on the head or trunk and an excellent prognosis. Histologically similar lymphomas may occur on the legs. The clinical behavior of this group is still undefined, and controversy exists whether these lymphomas should be classified as follicular center cell lymphoma or B-immunoblastic lymphoma. We reviewed the clinical, histologic, and follow-up data of 18 patients with primary cutaneous large B-cell lymphoma of the legs.
Primary cutaneous large B-cell lymphoma of the legs generally occurred in elderly patients (median age at diagnosis, 76 years), in particular women (male-female ratio, 7:2), and preferentially affected the lower legs (14 of 18 patients). Radiotherapy and/or systemic polychemotherapy resulted in complete remissions in 16 of 17 patients. Follow-up data demonstrated estimated 2- and 5-year survival rates of 77% and 58%, respectively. Histologic evaluation showed diffuse dermal infiltrates with variable proportions of centroblasts (large noncleaved cells), large centrocytes (large cleaved cells), and B immunoblasts. Seventeen of 18 patients were diagnosed as having primary cutaneous follicular center cell lymphoma; only 1 patient, whose histologic examination showed more than 30% immunoblasts, was diagnosed as having B-immunoblastic lymphoma.
Primary cutaneous large B-cell lymphoma of the legs is a distinct clinicopathologic entity that mainly affects elderly patients and has an intermediate prognosis. Although most cases have a follicular center cell origin, primary cutaneous large B-cell lymphoma is proposed as the most appropriate term for this type of cutaneous lymphoma.
原发性皮肤滤泡中心细胞淋巴瘤是一种独特类型的皮肤B细胞淋巴瘤,临床特征为头部或躯干出现局限性皮肤损害,预后良好。组织学上类似的淋巴瘤可发生于腿部。该组淋巴瘤的临床行为仍不明确,对于这些淋巴瘤应归类为滤泡中心细胞淋巴瘤还是B免疫母细胞淋巴瘤存在争议。我们回顾了18例原发性腿部皮肤大B细胞淋巴瘤患者的临床、组织学及随访数据。
原发性腿部皮肤大B细胞淋巴瘤通常发生于老年患者(诊断时中位年龄76岁),尤其是女性(男女比例为7:2),且以下肢受累为主(18例患者中有14例)。放疗和/或全身多药化疗使17例患者中的16例完全缓解。随访数据显示,估计2年和5年生存率分别为77%和58%。组织学评估显示真皮弥漫性浸润,伴有不同比例的中心母细胞(大无裂细胞)、大中心细胞(大裂细胞)和B免疫母细胞。18例患者中有17例被诊断为原发性皮肤滤泡中心细胞淋巴瘤;仅1例组织学检查显示免疫母细胞超过30%的患者被诊断为B免疫母细胞淋巴瘤。
原发性腿部皮肤大B细胞淋巴瘤是一种独特的临床病理实体,主要影响老年患者,预后中等。尽管大多数病例起源于滤泡中心细胞,但原发性腿部皮肤大B细胞淋巴瘤被认为是这类皮肤淋巴瘤最合适的术语。